obasanjo cv

Upload: the-florida-times-union

Post on 03-Apr-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/28/2019 Obasanjo CV

    1/6

    Olugbenga O. Obasanjo

    A public health professional with real world and didactic leadership experience in developing anddelivering healthcare business models. A unique exposure to healthcare practice and delivery in

    clinical settings, in the academic setting, as a private entrepreneur and all three tiers of government, in

    the United States of America and in Africa

    Address: 7818 Cedar Branch Drive, Gainesville Virginia 20155 USA

    Email: [email protected],[email protected], [email protected]

    Contact phone: +1 347 254 0188Born: November 20, 1971; US Citizen

    EDUCATION

    Date Discipline Degree Institution2013 Medical Services Management MBA Johns Hopkins School of Business

    1999 Infectious Disease Epidemiology Ph. D Johns Hopkins University

    1996 Epidemiology MPH Johns Hopkins University

    1994 Medicine and Surgery MBBS University of Ibadan

    MEDICAL LICENSURE

    2010 Virginia, United States of America

    2002 Indiana, United States of America

    1995 Nigeria

    MEDICAL RESIDENCY TRAINING

    20002001 Preventive Medicine Johns Hopkins University ResidentBloomberg School of Public Health

    19981999 Internal Medicine Greater Baltimore Medical Center Intern

    mailto:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]
  • 7/28/2019 Obasanjo CV

    2/6

    PROFESSIONAL CERTIFICATION2012 Certified Medical Review Officer by the Medical Review Officer Certification Council

    2012 American College of Health Executives Board of Governors Examination Diploma

    2011 Certificate in Business of Medicine by the Johns Hopkins Carey School of Business

    2010 Board Certification in Public Health by the National Board of Public Health Examiners

    2003 Board Certification in Preventive Medicine by the American Board of Preventive

    Medicine

    POSTDOCTORAL TRAINING

    20012002 Harvard School of Public Health Research Associate

    Worked with the AIDS Prevention Initiative in Nigeria (APIN) project of the Bill and Melinda Gates

    Foundation to develop and deliver health policy and programs to control and prevent HIV infection in

    Nigeria

    Help the National AIDS control program to identify and set priorities for HIV control Identify public and private stakeholders in HIV control and organize for a to enable interaction

    and development of skill sets to improve their delivery capacity

    Help identify social determinants of transmission of HIV in Nigeria Perform laboratory analyses to help monitor the impact of control measures undertaken by

    APIN and other stake holders

    19961999 Johns Hopkins Bloomberg School of Public Health Research Assistant

    Worked on an NIH funded grant on the geographical determinants of tuberculosis in Baltimore city

    Accessed all the data used to analyze significant part of the grant from the records of theBaltimore city Health Department

    Cleaned and analyzed the data and eventually developed the material into a PhD thesis Developed the results of the for publication Was involved in teaching of students and in helping to develop masters theses and in writing

    NIH funded grants

  • 7/28/2019 Obasanjo CV

    3/6

    EMPLOYMENT

    2011- Date Prince William County, Virginia Department of Health Public Health Physician

    Physician in charge of the tuberculosis, sexually transmitted diseases, travel and refugee clinics for the

    county health department and the county free clinic

    2010-Date Department of Epidemiology and Biostatistics, University of Maryland School of

    Public Health Adjunct Assistant Professor

    Organize, taught and graded the Introduction to Infectious Disease Epidemiology class in the school

    2010-date Medical officer in the commissioned corps of the United States Army Reserves

    2009-2011 Center for Food Safety and Applied Nutrition (FDA) ORISE Fellow

    Monitor epidemiological trends of food safety in the United States Monitored and analyzed data from the CAERS database, a passive database of reported food

    adverse events in the United States

    Monitored and advised on all reported food outbreaks in the United States; participated inIncidence Management Groups of national outbreak investigations

    Developed new methods of surveillance and identifying epidemiological trends in food safetyissues.

    Part ofSalmonella enteritidis workgroup, wrote the summary of illness between 2000 and2010

    Wrote a Medscape summary on Food-borne illness for healthcare practitioners Daily review of adverse event reports forunusual ingredients in a product leading to an

    adverse event or any unusual adverse event associated with a product.

    2004- 2009 Health AIDS Support Services Chief Executive

    Designed, developed and ran a healthcare delivery business in Nigeria

    Developed health communication intervention programs for private companies and governmentat 3 tiers in Nigeria

    Involved in procurement and supplies of pharmaceutical and medical equipment to public andprivate institution s in Nigeria

    Carried out health tourism programs for individuals and a contractor to 3 state governments inNigeria

    2003- 2004 State House Clinic, Abuja, Nigeria Staff Physician

    Responsible for treating staff of the State House (equivalent of the White House) and other workers of

    the Federal government of Nigeria

    19961997 Maryland Department of Health and Mental Hygiene Epidemiologist

  • 7/28/2019 Obasanjo CV

    4/6

    Responsible for monitoring the different databases maintained by the department. Was involved in the

    evolving Maryland electronic reporting and surveillance system (MERSS)

    PROFESSIONAL ACTIVITIES/LEADERSHIP2012 American Association of Public Health Physicians Member, Board of Trustees

    19992002 Johns Hopkins School of Public Health Alumni Assoc Vice President Africa

    Corresponding with alumni in Africa and maintain a network of African alumni. Identify resources for

    improving health outcomes in Africa using alumni skills and assets. Increase interest and enrollment inthe school among Africans

    19962001 Johns Hopkins Hospital Investigative Epidemiologist

    Served as a member of a team selected to investigate and analyze disease outbreaks in the hospital by

    the Hospital epidemiologist

    HONORS2012 Delta Omega Honorary Society in Public Health

    2010 Fellow of the American College of Preventive Medicine

    1996 Deans List, Johns Hopkins University Bloomberg School of Public Health1996 Convocation speaker, Johns Hopkins University Bloomberg School of Public Health

    MEMBERSHIPS

    American College of Preventive MedicineAmerican College of Healthcare Executives

    American College of Physician Executives

    Virginia Public Health AssociationAmerican Association of Public Health Physicians

    The Johns Hopkins University Alumni Association

    PAST ACTIVITIES (1999-2009)Director of Health Aids Support Services

    Director of Damtol Nigeria Health Tourism Limited

    Director of Zerock Construction Nigeria LimitedDirector of Linetrale oil trading company limited (Nigerian partner of PETROSA)

    Director of Global haulage Resources Limited

    Director of Vantage Assurance Ltd, Insurance brokers

    Director of Trinity Biotech, manufacturers of HIV test kits in NigeriaThe Alumni Advisory Council of the Johns Hopkins University (1999-2002)

  • 7/28/2019 Obasanjo CV

    5/6

    PUBLICATIONS/ABSTRACTS

    Obasanjo OO, Shields T, Coggin W, Chaisson RE, Glass GE. The Impact of Directly ObservedTherapy for Tuberculosis on Loss to Follow up in Baltimore City.International Journal of Businessand Social Science 3(2) 51-55 (2012)

    Obasanjo OO. (October 2011). Dietary supplements and the clinical encounter.Medscape PublicHealth and Prevention. Retrieved from http://www.medscape.com/viewarticle/751979

    Obasanjo OO. (August 2010). Food-borne Illness Primer for Physicians and Other Health CareProfessionals: A Review.Medscape Public Health and Prevention. Retrieved from

    http://www.medscape.com/viewarticle/726313

    Obasanjo OO, Kumwenda M. Factors Relating to Attrition in a Cohort Study of HIV in Malawi. East

    Afr. Med. J. 86(8) 399-408 (2009)

    Sierra B, Alegre R, Prez AB, Garcia G, Sturn-Ramirez K, Obasanjo O, Aguirre E, Alvarez M,Rodriguez-Roche R, Valds L, Kanki P, Guzmn MG. HLA-A, -B, -C, and -DRB1 allele frequencies

    in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for

    HLA studies of dengue virus infection.Hum Immunol. 68(6):531-40 (2007)

    Health AIDS Support Services. A Survey report on Baseline Needs assessment on Health Services in

    Kebbi State: Project of Kebbi State Action Committee on AIDS (KEBSACA). June 2006. Available onwww.hass-ng.com

    Health AIDS Support Services. Baseline Survey on Reproductive Health Related Perceptions and

    Behavior among MTN Workforce in Nigeria: Report on Main Findings. January 2005. Available on

    www.hass-ng.com

    Ranjan, A., Tarigopula, L., Obasanjo, OO, Obah, E. Effectiveness of a Clinical Pathway in theManagement of Congestive Heart Failure. South Med J. 96(7): 661-3 (2003)

    Obasanjo, O., Wu, P., Conlon, M., Karanfil, L., Pryor, P., Moler, G., Anhalt, G., Chaisson, R., Perl, T.

    An Outbreak of Scabies in a Teaching Hospital: Lessons learned. Infect Control Hosp Epidemiol22:13-18 (2001)

    Lyke, K., Obasanjo, O., Williams, M., OBrien, M., Chotani, R., Perl, T. Ventriculitus complicating

    use of intraventricular catheters in adult neurosurgical patients. Clinical Infect Dis33(12) 2028-33

    (2001)

    Golub, J., Cronin, W., Obasanjo, O., Coggin, W., Moore, K., Pope, D., Thompson, D., Sterling, T.,Harrington, S., Bishai, W., Chaisson, R. Transmission of Mycobacterium tuberculosis through casual

    contact with an infectious case. Arch Intern Med161(18) 2254-8 (2001)

    Obasanjo, O., Perl, T. Cost-benefit and effectiveness of nosocomial surveillance methods. CurrClinc Top Infect Dis21 391-406 (2001)

    http://www.ncbi.nlm.nih.gov/pubmed/17509453?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2http://www.ncbi.nlm.nih.gov/pubmed/17509453?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2http://www.ncbi.nlm.nih.gov/pubmed/17509453?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2http://www.hass-ng.com/http://www.hass-ng.com/http://www.hass-ng.com/http://www.ncbi.nlm.nih.gov/pubmed/17509453?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2http://www.ncbi.nlm.nih.gov/pubmed/17509453?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2http://www.ncbi.nlm.nih.gov/pubmed/17509453?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2
  • 7/28/2019 Obasanjo CV

    6/6

    Rao, S., Mookerjee, A., Obasanjo, O., Chaisson, R. Errors in Treatment of Tuberculosis in Baltimore.

    Chest117:734-737 (2000)

    Celentano, D., Vlahov, D., Cohn, S., Shadle, V., Obasanjo, O., l. Moore, R. Self-Reported

    Antiretroviral Therapy for HIV Infection among Injection Drug Users. JAMA280(6) 544-6 (1998)